The efficacy and safety of oral disease-modifying therapies for relapsing-remitting multiple sclerosis: A systematic review

Background: Although widely used, first-line injectable medicines for the treatment of multiple sclerosis (MS) remain an issue of efficacy and adherence. Recently, new oral medications for MS have contributed to dramatic improvements in MS treatment. This study aims to evaluate the safety and effica...

Descripción completa

Detalles Bibliográficos
Autores principales: Shahtaheri, Rahil Sadat, Nikfar, Shekoufeh, Khorasani, Elahe, Sabbagh-Baniazad, Mansoureh, Goudarzi, Zahra, Emamikhah, Maziar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185589/
http://dx.doi.org/10.18502/cjn.v19i3.5427

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185589/
http://dx.doi.org/10.18502/cjn.v19i3.5427

Ejemplares similares